Chevy Chase Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.93M Sell
98,743
-2,945
-3% -$270K 0.03% 424
2025
Q4
$9.14M Sell
101,688
-620
-0.6% -$58.8K 0.02% 428
2025
Q3
$10.1M Sell
102,308
-3,305
-3% -$327K 0.03% 404
2025
Q2
$9.63M Buy
105,613
+99
+0.1% +$9.57K 0.03% 414
2025
Q1
$11.9M Sell
105,514
-1,074
-1% -$115K 0.04% 362
2024
Q4
$11.3M Sell
106,588
-4,725
-4% -$507K 0.03% 379
2024
Q3
$12M Sell
111,313
-3,227
-3% -$352K 0.04% 370
2024
Q2
$12.4M Sell
114,540
-3,464
-3% -$408K 0.04% 346
2024
Q1
$15.6M Sell
118,004
-858
-0.7% -$107K 0.05% 310
2023
Q4
$14.5M Sell
118,862
-720
-0.6% -$80.3K 0.05% 310
2023
Q3
$13.4M Sell
119,582
-2,526
-2% -$321K 0.05% 300
2023
Q2
$17.8M Sell
122,108
-2,785
-2% -$378K 0.07% 266
2023
Q1
$16.1M Buy
124,893
+1,152
+0.9% +$145K 0.06% 281
2022
Q4
$15.8M Sell
123,741
-7,420
-6% -$861K 0.07% 272
2022
Q3
$13.7M Buy
131,161
+1,153
+0.9% +$127K 0.06% 291
2022
Q2
$13.7M Buy
130,008
+676
+0.5% +$80.2K 0.06% 305
2022
Q1
$16.5M Sell
129,332
-3,259
-2% -$393K 0.06% 302
2021
Q4
$16.4M Sell
132,591
-3,038
-2% -$398K 0.05% 313
2021
Q3
$19.3M Sell
135,629
-5,161
-4% -$759K 0.07% 263
2021
Q2
$22M Sell
140,790
-7,061
-5% -$1.14M 0.07% 247
2021
Q1
$23M Sell
147,851
-10,410
-7% -$1.61M 0.08% 233
2020
Q4
$23.7M Sell
158,261
-4,450
-3% -$629K 0.08% 225
2020
Q3
$21.5M Sell
162,711
-13,271
-8% -$1.73M 0.09% 215
2020
Q2
$20.4M Sell
175,982
-8,821
-5% -$1.02M 0.08% 225
2020
Q1
$18.1M Buy
184,803
+3,061
+2% +$401K 0.08% 224
2019
Q4
$26.4M Buy
181,742
+365
+0.2% +$50.4K 0.1% 210
2019
Q3
$24.2M Buy
181,377
+995
+0.6% +$129K 0.1% 219
2019
Q2
$20.6M Buy
180,382
+318
+0.2% +$37.2K 0.09% 245
2019
Q1
$21.5M Buy
180,064
+2,259
+1% +$257K 0.09% 234
2018
Q4
$17.9M Buy
177,805
+753
+0.4% +$84.7K 0.09% 233
2018
Q3
$22.6M Sell
177,052
-4,070
-2% -$484K 0.09% 226
2018
Q2
$19.6M Sell
181,122
-190
-0.1% -$20.7K 0.08% 246
2018
Q1
$19.2M Sell
181,312
-2,756
-1% -$320K 0.09% 250
2017
Q4
$21.6M Buy
184,068
+45
+0% +$5.09K 0.09% 246
2017
Q3
$20.9M Buy
184,023
+2,718
+1% +$314K 0.09% 245
2017
Q2
$22.6M Buy
181,305
+242
+0.1% +$28.7K 0.11% 217
2017
Q1
$21.5M Buy
181,063
+6,404
+4% +$726K 0.11% 228
2016
Q4
$17.5M Buy
174,659
+454
+0.3% +$48.7K 0.09% 246
2016
Q3
$22M Sell
174,205
-2,879
-2% -$356K 0.12% 198
2016
Q2
$20.7M Buy
177,084
+19,441
+12% +$2.2M 0.12% 210
2016
Q1
$16.3M Buy
157,643
+10,406
+7% +$1.01M 0.09% 251
2015
Q4
$14.7M Buy
147,237
+1,248
+0.9% +$122K 0.09% 266
2015
Q3
$13.3M Buy
145,989
+4,915
+3% +$493K 0.08% 276
2015
Q2
$15M Buy
141,074
+2,948
+2% +$326K 0.09% 260
2015
Q1
$15.8M Buy
138,126
+4,829
+4% +$551K 0.1% 250
2014
Q4
$14.7M Sell
133,297
-912
-0.7% -$96.1K 0.09% 256
2014
Q3
$13.1M Buy
134,209
+8,949
+7% +$880K 0.08% 262
2014
Q2
$12.6M Sell
125,260
-3,306
-3% -$323K 0.09% 263
2014
Q1
$11.8M Sell
128,566
-1,517
-1% -$140K 0.08% 273
2013
Q4
$11.8M Buy
130,083
+2,386
+2% +$206K 0.09% 264
2013
Q3
$10.2M Buy
127,697
+3,718
+3% +$293K 0.08% 286
2013
Q2
$9.02M Buy
+123,979
New +$9.27M 0.08% 292

Other funds holding ZBH

Chevy Chase Trust's ZBH Position: Q1 2026 in Review

Chevy Chase Trust reduced its Zimmer Biomet (ZBH) stake by 2.9% in Q1 2026, selling an estimated $270K and leaving 98,743 shares worth $8.93M. The position accounts for 0.03% of the portfolio, ranked #424.

Chevy Chase Trust first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.4M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Chevy Chase Trust held 98,743 shares of Zimmer Biomet worth $8.93M as of Q1 2026.
  • Chevy Chase Trust sold 2,945 Zimmer Biomet shares in Q1 2026, an estimated $270K.
  • Zimmer Biomet made up 0.03% of Chevy Chase Trust's portfolio in Q1 2026, its #424 holding.
  • Chevy Chase Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's Zimmer Biomet position peaked at $26.4M in Q4 2019.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.